Guided vs Potent P2Y12 Inhibitor Therapy in ACS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials
Eur Heart J 2021 Dec 16;[EPub Ahead of Print], M Galli, S Benenati, F Franchi, F Rollini, D Capodanno, G Biondi-Zoccai, GM Vescovo, LH Cavallari, B Bikdeli, J Ten Berg, R Mehran, CM Gibson, F Crea, NL Pereira, D Sibbing, DJ AngiolilloFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.